Prospective observational study for advanced lung cancer with interstitial lung disease

Prospective observational study for advanced lung cancer with interstitial lung disease - Advanced lung cancer with interstitial lung disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019370

Enrollment

300

Registered

2015-11-01

Start date

2015-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced lung cancer with interstitial lung disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with primary lung cancer with histopathological evidence 2. Chemotherapy-naiive 3. Advanced clinical stage without indication for curative surgery and radiotherapy 4. Preexisting interstitial lung disease on chest computed tomography at the time of lung cancer diagnosis 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Post-radiation fibrosis alone

Design outcomes

Primary

Measure	Time frame
Safety, particulary for the frequency and severity of chemotherapy-induced acute exacerbation of interstitial lung disease	—

Secondary

Measure	Time frame
Efficacy including response rate and progression-free survival	—

Countries

Japan

Contacts

Public ContactYasunori Enomoto

Hamamatsu University School of Medicine Second division, Department of internal medicine

enomotoy@hama-med.ac.jp+8153-435-2263

Outcome results